表柔比星是一种细胞渗透性的蒽环类抗肿瘤抗生素。它是多柔比星表现出降低心脏毒性的立体异构体（4'-表异构体）。它常用来抑制拓扑异构酶II和DNA解旋酶的活性。表柔比星是用来研究转移性乳腺癌和心脏毒性。 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia in solvent : -80°C, 6 months; -20°C, 1 month (protect from light) This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia Epirubicin is a cell-permeable anthracycline antitumor antibiotic. It is a stereoisomer(4′-epi-isomer) of doxorubicin that exhibits reduced cardiotoxicity. It is used to inhibit topoisomerase II and DNA helicase activity. Epirubicin is used to study metastatic breast cancerand cardiac toxicity. in solvent : -80°C, 6 months; -20°C, 1 month (protect from light)